PuSH - Publication Server of Helmholtz Zentrum München

Deshpande, D.* ; Agarwal, N.* ; Fleming, T.* ; Klose, C.S.N.* ; Tappe-Theodor, A.* ; Kuner, R.* ; Nawroth, P.P.

Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy.

Nat. Commun. 12:426 (2021)
Publ. Version/Full Text DOI
Open Access Gold
Creative Commons Lizenzvertrag
Painful neuropathy is a frequent complication in diabetes. Proopiomelanocortin (POMC) is an endogenous opioid precursor peptide, which plays a protective role against pain. Here, we report dysfunctional POMC-mediated antinociception in sensory neurons in diabetes. In streptozotocin-induced diabetic mice the Pomc promoter is repressed due to increased binding of NF-kB p50 subunit, leading to a loss in basal POMC level in peripheral nerves. Decreased POMC levels are also observed in peripheral nervous system tissue from diabetic patients. The antinociceptive pathway mediated by POMC is further impaired due to lysosomal degradation of μ-opioid receptor (MOR). Importantly, the neuropathic phenotype of the diabetic mice is rescued upon viral overexpression of POMC and MOR in the sensory ganglia. This study identifies an antinociceptive mechanism in the sensory ganglia that paves a way for a potential therapy for diabetic neuropathic pain.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Proopiomelanocortin Gene-expression; Peripheral Sensory Neurons; Factor-kappa-b; Opioid Receptor Phosphorylation; Kinase-c Isoforms; Beta-endorphin; Metabolic Dysfunction; Channel Function; Met-enkephalin; Ion-channel
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Quellenangaben Volume: 12, Issue: 1, Pages: , Article Number: 426 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
Grants Projekt DEAL